GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eco Animal Health Group PLC (LSE:EAH) » Definitions » Debt-to-Revenue

Eco Animal Health Group (LSE:EAH) Debt-to-Revenue : 0.05 (As of Sep. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Eco Animal Health Group Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Eco Animal Health Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was £0.93 Mil. Eco Animal Health Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was £3.20 Mil. Eco Animal Health Group's annualized Revenue for the quarter that ended in Sep. 2023 was £76.02 Mil. Eco Animal Health Group's annualized Debt-to-Revenue for the quarter that ended in Sep. 2023 was 0.05.


Eco Animal Health Group Debt-to-Revenue Historical Data

The historical data trend for Eco Animal Health Group's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eco Animal Health Group Debt-to-Revenue Chart

Eco Animal Health Group Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.05 0.01 0.02 0.05

Eco Animal Health Group Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.03 0.04 0.05

Competitive Comparison of Eco Animal Health Group's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Eco Animal Health Group's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eco Animal Health Group's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eco Animal Health Group's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Eco Animal Health Group's Debt-to-Revenue falls into.



Eco Animal Health Group Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Eco Animal Health Group's Debt-to-Revenue for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.884 + 3.596) / 85.311
=0.05

Eco Animal Health Group's annualized Debt-to-Revenue for the quarter that ended in Sep. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.934 + 3.204) / 76.018
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Sep. 2023) Revenue data.


Eco Animal Health Group Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Eco Animal Health Group's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Eco Animal Health Group (LSE:EAH) Business Description

Traded in Other Exchanges
N/A
Address
78 Coombe Road, New Malden, London, Surrey, GBR, KT3 4QS
Eco Animal Health Group PLC is engaged in the manufacture and marketing of animal health products. The company's product portfolio includes Aivlosin - macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry; Ecomectin, Eco heart, Ecotraz, and Ecomintic for treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry and cattle. The geographical segments of the company include Corporate/UK, China & Japan, North America, South & South East Asia, Latin America, Europe, and the Rest of the World.

Eco Animal Health Group (LSE:EAH) Headlines

No Headlines